| Followers | 30 |
| Posts | 3322 |
| Boards Moderated | 0 |
| Alias Born | 08/21/2015 |
Saturday, September 18, 2021 8:00:18 PM
“Then how come at least half of the 'giftors' to 13-D are financially involved in IncellDX?”
Half is not even close to correct (you’re off by 40%). There are 39 people listed as “gifting persons” to CCTV, which funded the 13d. There are another 41 people listed as having contributed funds, a few being repeats.
So there were 70-80 different people/entities that contributed to the 13d fund.
There are 7 people listed as investors in Incelldx who also contributed to the 13d fund. Those investors invested in Incelldx long before the 13d was ever formed.
If we use 70 as the total number of 13d contributors, only 10% are also Incelldx investors (7 of 70). Hardly a conspiracy, especially considering those 7 people own a combined 1% of Incelldx at the company’s $150 evaluation from April 2020.
The boogeymen that many hardcore NP-supporters touted as being behind the 13d are just investors (see the SEC filing).
The boogeymen the Pro-NP grouped claimed were pushing the 13d to buy Incelldx (which has proven to be false) is 7 investors, SEVEN, who own a whopping 1% of Incelldx (see the SEC filing). Really scary.
Half is not even close to correct (you’re off by 40%). There are 39 people listed as “gifting persons” to CCTV, which funded the 13d. There are another 41 people listed as having contributed funds, a few being repeats.
So there were 70-80 different people/entities that contributed to the 13d fund.
There are 7 people listed as investors in Incelldx who also contributed to the 13d fund. Those investors invested in Incelldx long before the 13d was ever formed.
If we use 70 as the total number of 13d contributors, only 10% are also Incelldx investors (7 of 70). Hardly a conspiracy, especially considering those 7 people own a combined 1% of Incelldx at the company’s $150 evaluation from April 2020.
The boogeymen that many hardcore NP-supporters touted as being behind the 13d are just investors (see the SEC filing).
The boogeymen the Pro-NP grouped claimed were pushing the 13d to buy Incelldx (which has proven to be false) is 7 investors, SEVEN, who own a whopping 1% of Incelldx (see the SEC filing). Really scary.
Recent CYDY News
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
